Indeed, our findings indicated that hepatic-specific deletion of SELENOS accelerated the onset and progression of obesity, impaired glucose tolerance and insulin sensitivity, and increased hepatic TG and diacylglycerol (DAG) accumulation. The gene discussed is INS; the disease is Obesity.